Navigation Links
VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis
Date:5/23/2011

rpharma is also well advanced in its planning of studies to determine the efficacy of VivaGel(R) for this second BV indication and expects to commence this trial in Q3 2011. The very high early cure rate observed in this study is an important observation that is highly relevant to and supportive of the application of VivaGel(R) for prevention of BV recurrence.

About Bacterial Vaginosis
BV is the most common vaginal infection worldwide and is particularly prevalent in the US, where it affects an estimated one-third of the adult female population. Similar to imbalances between "good" and "bad" bacteria in the gut, an imbalance in the vaginal microbiota between good bacteria - which help maintain a normal healthy vagina - and harmful bacteria, leads to BV with symptoms including vaginal irritation, discharge and odour that are unpleasant and disrupt and interfere with a woman's relationships and general quality of life. The condition also has more serious consequences, being implicated in pelvic inflammatory disease and associated with an increased risk of pre-term birth. BV also significantly increases the risk of some sexually transmitted infections, including HIV.

Several studies have found an association between BV and acquisition of HIV, with one study indicating that more than 30% of HIV infections in women could be prevented if BV was successfully treated. Therefore, treatment of BV with VivaGel(R) could have a positive indirect impact in reducing HIV acquisition.

Other Applications of VivaGel(R)
VivaGel(R) is also being developed as a topical microbicide for the prevention of HIV and genital herpes and as a condom coating. Prevention of human papillomavirus is also under assessment.  

For a copy of the clinical appendix please go to http://www.starpharma.com/news-room

For Further Information:
Media:
Buchan Consulting
Rebecca Wilson
Mob: +61-417-3
'/>"/>

SOURCE Starpharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... YORK , May 5, 2015  IBM Watson ... is collaborating with more than a dozen leading cancer ... and personalize treatment options for their patients. The institutes ... capabilities to reduce from weeks to minutes the ability ... and gather relevant information from medical literature to personalize ...
(Date:5/5/2015)... Pa. , May 5, 2015  The preclinical ... leader in pharmacokinetic testing of drugs and safety testing ... , Associate Director of Preclinical Studies, presented at this ... Vision and Ophthalmology (ARVO) in Denver, CO. ... was "Safety Assessment of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl ...
(Date:5/5/2015)... EAST LYME, Conn. , May 5, 2015 /PRNewswire/ ... used lab equipment in North America, has named industry veteran ... President of Business Development. Becorest will be based out ... office where her role will include expanding the company,s ... new strategic partnership opportunities. "ALT has been ...
Breaking Medicine Technology:Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3ALT Names Anggie Becorest Senior Vice President of Business Development 2
...  TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor ... of allergies, cold and flu symptoms and migraine headaches, ... Flu brand is receiving through the ongoing Social Media ... new homeopathic product, Thera Max® Cold and Flu into ...
... 2012  Essentialis, Inc., today announced Phase 2b trial results ... triglyceride (TG) levels by 30 to 40 percent in ... Triglycerides [VHTG]). The study included an arm combining DCCR ... the combination arm, DCCR was shown to be additive ...
Cached Medicine Technology:Thera Max® Cold and Flu Brand Receives Great Benefits from Its Ongoing Social Media Marketing Awareness Program 2Thera Max® Cold and Flu Brand Receives Great Benefits from Its Ongoing Social Media Marketing Awareness Program 3Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels 2Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels 3
(Date:5/5/2015)... The global lab automation market is ... Million in 2014, at an estimated CAGR of 6.7% ... automation market on the basis of equipment and software, ... the basis of application, Lab Automation Market is classified ... solutions. Drug discovery is a major application of the ...
(Date:5/5/2015)... TX (PRWEB) May 05, 2015 ... selected C.R. Bard Inc., a leading multinational developer, ... in the fields of vascular, urology, oncology and ... 2015 Vanguard Award. The Vanguard Award recognizes ... employee wellness programs among Viverae’s significant client base. ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Dr. Patricia ... pulmonary hypertension (PH). A pulmonologist and pulmonary hypertension specialist ... was attending a work event when an initial idea ... “I was sitting in the audience at the 2010 ... team of healthcare providers – were recalling their climb ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 In a April ... The Herald-Times , the Missouri State Highway Patrol (MSHP) ... Methamphetamine production or use for the second year in a ... to the FBI, reported 1,469 incidents in 2014 alone, around ... only around 2% of the US Population calls Indiana home, ...
(Date:5/5/2015)... 05, 2015 ProTexting, LLC – ... to deploy Mobile Engagement Campaigns and other Mobile solutions, ... clients can now leverage the power of Mobile Marketing ... syncing subscribers’ e-mail addresses into the Constant Contact Platform. ... that the growing trend of multi-channel marketing would become ...
Breaking Medicine News(10 mins):Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... Parents offered genetic testing to predict their risks of ... children. That is the finding of a new study ... online April 18). The study authors note these and ... chose predictive genetic tests for themselves and for their children, ...
... the first time, scientists have made star-shaped, biodegradable polymers ... the spheres are injected with cells into wounds, these ... new tissue. Developing this nanofiber sphere as ... of the cell is a very significant advance in ...
... Steven Reinberg HealthDay Reporter , FRIDAY, April 15 ... lies may be showing early signs of dementia, researchers from ... may help doctors diagnose which type of dementia a patient ... "The different dementia patients tended to have difficulty identifying ...
... Meat and poultry sold in the United States is widely ... bacteria that can cause serious illnesses in humans, a new ... to S. aureus range from mild skin infections ... In the new nationwide study, researchers analyzed 136 samples ...
... HealthDay Reporter , FRIDAY, April 15 (HealthDay News) -- Is ... in the Journal of the American Medical Association , ... suggested the latter when it found a reduced risk of ... therapy. This seemed to contradict years of cautions ...
... 15, 2011) Strains of genital herpes in Africa ... States, researchers at Harvard Medical School report, a striking ... preventing HIV transmission in a region staggered by the ... testing mouse model strains of the disease against vaccine ...
Cached Medicine News:Health News:Study: Parents likely to embrace predictive genetic testing for their children if offered 2Health News:Study: Parents likely to embrace predictive genetic testing for their children if offered 3Health News:Researchers inject nanofiber spheres carrying cells into wounds to grow tissue 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 3Health News:Drug-Resistant Staph Bacteria Found in Meat, Poultry Nationwide 2Health News:Drug-Resistant Staph Bacteria Found in Meat, Poultry Nationwide 3Health News:Estrogen's Role in Breast Cancer Can Fluctuate 2Health News:Estrogen's Role in Breast Cancer Can Fluctuate 3Health News:Genital herpes more virulent in Africa than in US 2Health News:Genital herpes more virulent in Africa than in US 3
... This unique system uses prolene as thread-guide ... The hollow Ritleng Probe is inserted into the ... fed through it. The probe is then withdrawn ... mm 0.64 mm diam silicone tubing into place. ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... Ultra-thin collarette conforms to natural anatomy ... Pre-loaded on disposable inserter/dilator instrument for ease ... Slim Mini and Slim Petite plugs offer ... The Slim plugs are made of the ...
For use with Crawford Intubation Systems....
Medicine Products: